Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

Clinical trial NCT06069570 · RECRUITING

Trial details

NCT number: NCT06069570
Sponsor: Kiromic BioPharma Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Cancer Bone Metastases From Solid Tumors

Start date: 2023-11-07
Primary completion: 2025-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.